
The shares are or may become issuable upon exercise of outstanding Series B Warrants which were issued in the public offering that closed on February 15, 2024, have a current
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SBFM | Sunshine Biopharma | 2.30 | -269.20 | -99.15% |
| Name | Price | % Change | |
|---|---|---|---|
| $2.30 | -99.15% |

The shares are or may become issuable upon exercise of outstanding Series B Warrants which were issued in the public offering that closed on February 15, 2024, have a current

Sunshine Biopharma, Inc. (SBFM) is scheduled to report 3rd quarter earnings on 11/10/2026. Regarding Q3 estimates, Wall Street analysts expect Sunshine Biopharma, Inc. to post earnings of -$3.40 per share.

19:50 EDT Sunshine Biopharma (SBFM) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks

Sunshine Biopharma (SBFM) announced a one for twenty reverse split of its common stock, effective at market open on October 26, 2026. The reverse stock split was undertaken to regain

The latest update is out from Sunshine Biopharma ( ($SBFM) ). On October 13, 2026, Sunshine Biopharma’s CEO, Dr. Steve N. Slilaty, who controls about 90% of the company’s voting

Sunshine Biopharma ( ($SBFM) ) has provided an update. On October 8, 2026, Sunshine Biopharma entered a placement agent agreement with Aegis Capital for a reasonable best efforts public offering

Sunshine Biopharma (SBFM) announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $6.0 million, before

Aegis Capital is acting as exclusive placement agent in connection with this offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See

Sunshine Biopharma (SBFM) has launched generic Ondansetron tablets of 4mg and 8mg in the Canadian market. Ondansetron is the generic equivalent of the brand name, Zofran. Ondansetron is widely prescribed

Sunshine Biopharma ( ($SBFM) ) just unveiled an update. On September 15, 2026, Sunshine Biopharma’s majority voting shareholder and CEO, Dr. Steve N. Slilaty, approved a written consent authorizing the
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| May 20, 2027TBA | $1.94M | ― | ― | 0.01 | -0.01 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.